Jeena Sikho Lifecare Limited — Investor Meet, 21-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Jeena Sikho Lifecare reported strong Q1 FY'26 results with revenue at INR174 Cr, up 74% YoY, and PAT at INR51 Cr, up 218% YoY. EBITDA margin was robust at 45%. The company continues expanding its hospital footprint, adding 390 beds for a total of 2,570 operational beds. A new OTC product, "PET Liver Spleen Shuddi Kit," is set for official launch, targeting INR500 Cr turnover in 1.5-2 years with 20% PAT margin. Management highlighted increasing bed occupancy, reducing government receivables, and leveraging college tie-ups for expansion. The outlook is confident on sustained growth and expanding Ayurveda's reach.